Russell Skibsted

Companies

• Processa Pharmaceuticals, Inc.Chief financial officer Jul 18, 2024 to now¹
• Alimera SciencesChief financial officer Jan 10, 2023 to Nov 28, 2023²
• Rockwell Medical Inc.Officer Sep 16, 2020 to Sep 13, 2022³
• Serina Therapeutics, Inc.Chief financial officer Nov 27, 2018 to Feb 14, 2019⁴
• Lineage Cell TherapeuticsChief financial officer Nov 27, 2015 to Dec 20, 2018⁵
• Insight Molecular Diagnostics Inc.Chief financial officer Dec 31, 2015 to Dec 31, 2015⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPProcessa Pharmaceuticals, Inc. PCSA16,689 shares⁷$28.9K at $1.73Jul 28, 2026
• ASAlimera Sciences ALIM75,500 shares⁸Nov 28, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 30, 2026Bought 3,277 shares at $1.93 of Processa Pharmaceuticals, Inc.⁹
• Jun 15, 2026Bought 2,654 shares at $2.22 of Processa Pharmaceuticals, Inc.¹⁰
• May 29, 2026Bought 2,292 shares at $2.57 of Processa Pharmaceuticals, Inc.¹¹
• May 15, 2026Bought 1,984 shares at $2.97 of Processa Pharmaceuticals, Inc.¹²
• Apr 30, 2026Bought 2,190 shares at $2.69 of Processa Pharmaceuticals, Inc.¹³
• Apr 15, 2026Bought 1,984 shares at $2.97 of Processa Pharmaceuticals, Inc.¹⁴
• Mar 31, 2026Bought 2,324 shares at $2.54 of Processa Pharmaceuticals, Inc.¹⁵
• Mar 26, 2023Granted 58,000 shares of Alimera Sciences¹⁶
• Jan 9, 2023Granted 17,500 shares of Alimera Sciences¹⁷